Clinical Trial

Diagnosis and Treatment of Patients With Inborn Errors of Metabolism

Recruiting
View on ClinicalTrials.gov →
Summary
Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be examined and treated on an out patient basis, if practical. However, patients requiring specialized tests or treatments will be admitted to the NIH Clinical Center as necessary. Researchers will use only accepted medical procedures in diagnosing (medical history, physical examinations, X-ray studies, eye examinations, blood tests, and urine tests) and treating the patients involved in this study. Additional tests may be required on a case to case basis. Many patients seen in this study will go on to be enrolled in a specific disease-related research study.\<TAB\>
Protocol Amendment History 335 amendments
This ClinicalTrials.gov record has been amended 335 times since 2006-08-25; most recent amendment 2026-07-15.
Trial Details
NCT Number NCT00369421
Lead Sponsor National Human Genome Research Institute (NHGRI)
Conditions Arterial Calcification Due to Deficiency of CD73
Enrollment 4,000 participants
Start Date 1978-09-12
Updated on ClinicalTrials.gov 2026-08-03